Miejski Szpital Zespolony W Olsztynie
- Address
- Aleja Wojska Polskiego 30, 10-229 Olsztyn, Poland
Cardiovascular Diseases
The Klinika Kardiologii i Chorób Wewnętrznych at Miejski Szpital Zespolony W Olsztynie conducts studies targeting heart failure, with a focus on reducing cardiovascular death and enhancing patients' physical function.
- Evaluation of novel oral agents for HFmrEF/HFpEF
- Assessment of clinical outcomes such as cardiovascular mortality and hospitalization
- Exploration of functional capacity and symptom relief
Ongoing research seeks to compare new therapies against standard care, aiming to improve long‑term prognosis for individuals living with chronic heart conditions.
Skin and Connective Tissue Diseases
Researchers are investigating innovative treatments for cutaneous lupus erythematosus, a challenging autoimmune skin disorder, to determine whether new agents can provide superior skin clearance compared with placebo.
- Measurement of skin lesion improvement at 24 weeks
- Evaluation of safety and tolerability of targeted biologics
- Investigation of disease activity biomarkers
The goal is to expand therapeutic options for patients whose skin symptoms significantly impact quality of life, while ensuring a favorable safety profile.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Leo Pharma A/S1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1MoonLake Immunotherapeutics AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Miejski Szpital Zespolony W Olsztynie
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Anifrolumab in Refractory Chronic and Subacute Cutaneous Lupus Erythematosus: A Phase III Randomized, Double-Blind, Placebo-Controlled Study | AstraZeneca AB | Phase III | Not Recruiting | Sep 2024 | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sonelokimab | 2 | Unknown | 2024-09-24 | 2025-10-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.